Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer

DICRU, D0.1cc, D1cc, and D2cc are relevant for predicting late rectal toxicities. The patients with bladder D2cc > 95 Gy are required to be in close observation for severe late toxicities.